Over 10 years of experience in biomedical informatics research. I have led several real-world digital health studies for assessing personalized lived experiences in individuals with neurological and psychiatric diseases.
My research is focused on development and validation of fit-for-purpose & contextual real-world digital endpoints for neurological and mental health disorders. I am also interested in understanding and addressing differential community participation in mental health research that may introduce significant biases in health data gathering in an uncontrolled “real world” settings. I believe in order to improve population-level outcomes in mental health we need to learn locally about what kind of health assessments and mediation mechanisms work for whom, when, and for how long?
I collaborate with an amazingly diverse stakeholders in developing decentralized studies. These include but not limited to communities with lived experience, clinicians, patient advocates, scientists, health communication specialists, data scientists , engineers and governance experts.
PhD Biomedical Informatics (Digital Health)
University of Washington
MS Engineering Management (Computer Science)
University of Maryland, Baltimore County
Bachelors in Technology, Bioinformatics
VIT University
Responsibilities include:
Multiple sclerosis (MS) is a chronic neurodegenerative disease. Current monitoring practices predominantly rely on brief and infrequent assessments, which may not be representative of the real-world patient experience. Smartphone technology provides an opportunity to assess people’s daily-lived experience of MS on a frequent, regular basis outside of episodic clinical evaluations. The objectives of this study were to evaluate the feasibility and utility of capturing real-world MS-related health data remotely using a smartphone app, “elevateMS,” to investigate the associations between self-reported MS severity and sensor-based active functional tests measurements, and the impact of local weather conditions on disease burden.
Digital technologies such as smartphones are transforming the way scientists conduct biomedical research. Several remotely conducted studies have recruited thousands of participants over a span of a few months allowing researchers to collect real-world data at scale and at a fraction of the cost of traditional research. Unfortunately, remote studies have been hampered by substantial participant attrition, calling into question the representativeness of the collected data including generalizability of outcomes. We report the findings regarding recruitment and retention from eight remote digital health studies conducted between 2014–2019 that provided individual-level study-app usage data from more than 100,000 participants completing nearly 3.5 million remote health evaluations over cumulative participation of 850,000 days. Median participant retention across eight studies varied widely from 2–26 days (median across all studies = 5.5 days). Survival analysis revealed several factors significantly associated with increase in participant retention time, including (i) referral by a clinician to the study (increase of 40 days in median retention time); (ii) compensation for participation (increase of 22 days, 1 study); (iii) having the clinical condition of interest in the study (increase of 7 days compared with controls); and (iv) older age (increase of 4 days). Additionally, four distinct patterns of daily app usage behavior were identified by unsupervised clustering, which were also associated with participant demographics. Most studies were not able to recruit a sample that was representative of the race/ethnicity or geographical diversity of the US. Together these findings can help inform recruitment and retention strategies to enable equitable participation of populations in future digital health research.